Bernard F. Andruss, PhD
VP, Molecular Diagnostics Division
Learn More
Bernard F. Andruss, PhD
VP, Molecular Diagnostics Division
Dr. Andruss joined in March 2006. Bernard has significant R&D experience from his progressive roles at Ambion, Inc. where he helped initiate new R&D projects and expanded Ambion’s SBIR funding program. He assisted in the spinoff of Asuragen from Ambion and built a sponsored research program that has been awarded over $25M in funding. During his tenure at Asuragen, Bernard was responsible for leading many successful diagnostic product development programs. Prior to Ambion, he worked in progressive roles at in academia at Rice University and the University of Texas M. D. Anderson Cancer Center. Dr. Andruss received his Ph.D. in Biochemistry and Cell Biology from Rice University and his B.S. in Biochemistry from Texas A&M University.
Tom Copa
VP, Commercial MDD
Learn More
Tom Copa
VP, Commercial MDD
Mr. Copa joined in 2018 bringing extensive commercial leadership experience in health care and molecular diagnostics. He was most recently vice president of licensed technologies at the Luminex Corporation. In total, Tom spent over 16 years at Luminex as a senior executive in roles spanning sales, marketing, and business development in their clinical and life sciences divisions. He also brings with him over seven years of direct sales experience within the medical device market at Baxter Healthcare (now a part of Cardinal Health). Tom received his B.B.A. in Political Science from Marquette University.